These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11517398)

  • 1. HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity.
    Ross HL; Gartner S; McArthur JC; Corboy JR; McAllister JJ; Millhouse S; Wigdahl B
    J Neurovirol; 2001 Jun; 7(3):235-49. PubMed ID: 11517398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients.
    Burdo TH; Gartner S; Mauger D; Wigdahl B
    J Neurovirol; 2004; 10 Suppl 1():7-14. PubMed ID: 14982733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia.
    Burdo TH; Nonnemacher M; Irish BP; Choi CH; Krebs FC; Gartner S; Wigdahl B
    DNA Cell Biol; 2004 Apr; 23(4):261-9. PubMed ID: 15142383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression.
    Hogan TH; Stauff DL; Krebs FC; Gartner S; Quiterio SJ; Wigdahl B
    J Neurovirol; 2003 Feb; 9(1):55-68. PubMed ID: 12587069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage.
    Ross HL; Nonnemacher MR; Hogan TH; Quiterio SJ; Henderson A; McAllister JJ; Krebs FC; Wigdahl B
    J Virol; 2001 Feb; 75(4):1842-56. PubMed ID: 11160683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific.
    Hogan TH; Nonnemacher MR; Krebs FC; Henderson A; Wigdahl B
    Biomed Pharmacother; 2003 Jan; 57(1):41-8. PubMed ID: 12642036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
    Mondal D; Alam J; Prakash O
    J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineage.
    Dahiya S; Liu Y; Nonnemacher MR; Dampier W; Wigdahl B
    PLoS One; 2014; 9(2):e88116. PubMed ID: 24551078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR.
    Liu Y; Nonnemacher MR; Stauff DL; Li L; Banerjee A; Irish B; Kilareski E; Rajagopalan N; Suchitra JB; Khan ZK; Ranga U; Wigdahl B
    Biomed Pharmacother; 2010 Dec; 64(10):672-80. PubMed ID: 20970301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes.
    Henderson AJ; Zou X; Calame KL
    J Virol; 1995 Sep; 69(9):5337-44. PubMed ID: 7636977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of binding sites for members of the CCAAT/enhancer binding protein transcription factor family in the simian immunodeficiency virus long terminal repeat.
    Nonnemacher MR; Hogan TH; Quiterio S; Wigdahl B; Henderson A; Krebs FC
    Biomed Pharmacother; 2003 Jan; 57(1):34-40. PubMed ID: 12642035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes.
    Krebs FC; Mehrens D; Pomeroy S; Goodenow MM; Wigdahl B
    J Biomed Sci; 1998; 5(1):31-44. PubMed ID: 9570512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C/EBP- and Tat-mediated activation of the HIV-1 LTR in CD34+ hematopoietic progenitor cells.
    Quiterio S; Grant C; Hogan TH; Krebs FC; Wigdahl B
    Biomed Pharmacother; 2003 Jan; 57(1):49-56. PubMed ID: 12642037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of human immunodeficiency virus type 1 gene expression and pathogenesis by CCAAT/enhancer binding proteins in cells of the monocyte/macrophage lineage.
    Hogan TH; Krebs FC; Wigdahl B
    J Neurovirol; 2002 Dec; 8 Suppl 2():21-6. PubMed ID: 12491147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 LTR DNA sequence variation in brain-derived isolates.
    Corboy JR; Garl PJ
    J Neurovirol; 1997 Oct; 3(5):331-41. PubMed ID: 9372454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E(2)-mediated activation of HIV-1 long terminal repeat transcription in human T cells necessitates CCAAT/enhancer binding protein (C/EBP) binding sites in addition to cooperative interactions between C/EBPbeta and cyclic adenosine 5'-monophosphate response element binding protein.
    Dumais N; Bounou S; Olivier M; Tremblay MJ
    J Immunol; 2002 Jan; 168(1):274-82. PubMed ID: 11751971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
    Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C/EBP site in the feline immunodeficiency virus (FIV) long terminal repeat (LTR) is necessary for its efficient replication and is also involved in the inhibition of FIV LTR-directed gene expression by pseudorabies virus ICP4.
    Kawaguchi Y; Tomonaga K; Maeda K; Ono M; Miyazawa T; Kohmoto M; Tohya Y; Mikami T
    Virology; 1995 Apr; 208(2):492-9. PubMed ID: 7747422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site I.
    Shah S; Alexaki A; Pirrone V; Dahiya S; Nonnemacher MR; Wigdahl B
    Virol J; 2014 May; 11():92. PubMed ID: 24886416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.